SenzaGen AB (STO:SENZA)

SenzaGen AB Statistics

Total Valuation

SenzaGen AB has a market cap or net worth of SEK 173.59 million. The enterprise value is 153.32 million.

Market Cap	173.59M
Enterprise Value	153.32M

Important Dates

The last earnings date was Tuesday, May 12, 2026.

Earnings Date	May 12, 2026
Ex-Dividend Date	n/a

Share Statistics

SenzaGen AB has 32.51 million shares outstanding. The number of shares has increased by 5.72% in one year.

Current Share Class	32.51M
Shares Outstanding	32.51M
Shares Change (YoY)	+5.72%
Shares Change (QoQ)	+10.18%
Owned by Insiders (%)	24.95%
Owned by Institutions (%)	20.95%
Float	24.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.93
PB Ratio	1.89
P/TBV Ratio	3.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.97
EV / Sales	2.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.55

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.19.

Current Ratio	2.95
Quick Ratio	2.64
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	-1.57
Interest Coverage	-17.25

Financial Efficiency

Return on equity (ROE) is -12.72% and return on invested capital (ROIC) is -15.46%.

Return on Equity (ROE)	-12.72%
Return on Assets (ROA)	-5.97%
Return on Invested Capital (ROIC)	-15.46%
Return on Capital Employed (ROCE)	-10.33%
Weighted Average Cost of Capital (WACC)	6.81%
Revenue Per Employee	1.80M
Profits Per Employee	-332,545
Employee Count	33
Asset Turnover	0.52
Inventory Turnover	6.54

Taxes

Income Tax	-251,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.87% in the last 52 weeks. The beta is 0.54, so SenzaGen AB's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	-8.87%
50-Day Moving Average	5.29
200-Day Moving Average	5.77
Relative Strength Index (RSI)	47.64
Average Volume (20 Days)	21,380

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SenzaGen AB had revenue of SEK 59.28 million and -10.97 million in losses. Loss per share was -0.36.

Revenue	59.28M
Gross Profit	37.59M
Operating Income	-10.92M
Pretax Income	-11.23M
Net Income	-10.97M
EBITDA	-4.36M
EBIT	-10.92M
Loss Per Share	-0.36

Balance Sheet

The company has 38.06 million in cash and 17.78 million in debt, with a net cash position of 20.28 million or 0.62 per share.

Cash & Cash Equivalents	38.06M
Total Debt	17.78M
Net Cash	20.28M
Net Cash Per Share	0.62
Equity (Book Value)	91.72M
Book Value Per Share	2.82
Working Capital	42.83M

Cash Flow

In the last 12 months, operating cash flow was -8.59 million and capital expenditures -2.73 million, giving a free cash flow of -11.32 million.

Operating Cash Flow	-8.59M
Capital Expenditures	-2.73M
Depreciation & Amortization	6.56M
Net Borrowing	1.33M
Free Cash Flow	-11.32M
FCF Per Share	-0.35

Margins

Gross margin is 63.42%, with operating and profit margins of -18.42% and -18.51%.

Gross Margin	63.42%
Operating Margin	-18.42%
Pretax Margin	-18.94%
Profit Margin	-18.51%
EBITDA Margin	-7.35%
EBIT Margin	-18.42%
FCF Margin	n/a

Dividends & Yields

SenzaGen AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.72%
Shareholder Yield	-5.72%
Earnings Yield	-6.32%
FCF Yield	-6.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SenzaGen AB has an Altman Z-Score of 0.97 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.97
Piotroski F-Score	1